BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 22338048)

  • 1. Immunophenotypic analysis of myeloperoxidase-negative leukemia cutis and blastic plasmacytoid dendritic cell neoplasm.
    Cronin DM; George TI; Reichard KK; Sundram UN
    Am J Clin Pathol; 2012 Mar; 137(3):367-76. PubMed ID: 22338048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical analysis of CD123, CD56 and CD4 for the diagnosis of minimal bone marrow involvement by blastic plasmacytoid dendritic cell neoplasm.
    Hwang K; Park CJ; Jang S; Chi HS; Huh JR; Lee JH; Suh C; Lee KH
    Histopathology; 2013 Apr; 62(5):764-70. PubMed ID: 23470050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group.
    Tsagarakis NJ; Kentrou NA; Papadimitriou KA; Pagoni M; Kokkini G; Papadaki H; Pappa V; Marinakis T; Anagnostopoulos NI; Vadikolia C; Anagnostopoulos A; Angelopoulou MK; Terpos E; Poziopoulos C; Anargyrou K; Rontogianni D; Papadaki T; Psarra A; Kontopidou FN; Skoumi D; Papadhimitriou SI; Paterakis G;
    Leuk Res; 2010 Apr; 34(4):438-46. PubMed ID: 19793612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis.
    Petrella T; Meijer CJ; Dalac S; Willemze R; Maynadié M; Machet L; Casasnovas O; Vergier B; Teitell MA
    Am J Clin Pathol; 2004 Aug; 122(2):307-13. PubMed ID: 15323148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid Cell Nuclear Differentiation Antigen (MNDA) Expression Distinguishes Extramedullary Presentations of Myeloid Leukemia From Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Johnson RC; Kim J; Natkunam Y; Sundram U; Freud AG; Gammon B; Cascio MJ
    Am J Surg Pathol; 2016 Apr; 40(4):502-9. PubMed ID: 26796502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An updated approach to the diagnosis of myeloid leukemia cutis.
    Cronin DM; George TI; Sundram UN
    Am J Clin Pathol; 2009 Jul; 132(1):101-10. PubMed ID: 19864240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimized immunohistochemical panel to differentiate myeloid sarcoma from blastic plasmacytoid dendritic cell neoplasm.
    Sangle NA; Schmidt RL; Patel JL; Medeiros LJ; Agarwal AM; Perkins SL; Salama ME
    Mod Pathol; 2014 Aug; 27(8):1137-43. PubMed ID: 24390220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review.
    Rauh MJ; Rahman F; Good D; Silverman J; Brennan MK; Dimov N; Liesveld J; Ryan DH; Burack WR; Bennett JM
    Leuk Res; 2012 Jan; 36(1):81-6. PubMed ID: 21890199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blastic plasmacytoid dendritic cell neoplasm expressing the CD13 myeloid antigen.
    Inoue D; Maruyama K; Aoki K; Nagano S; Maruoka H; Imai Y; Ito K; Ishikawa T; Takahashi T
    Acta Haematol; 2011; 126(2):122-8. PubMed ID: 21701157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous manifestations of blastic plasmacytoid dendritic cell neoplasm-morphologic and phenotypic variability in a series of 33 patients.
    Cota C; Vale E; Viana I; Requena L; Ferrara G; Anemona L; Metze D; Fink-Puches R; Wiesner T; Cerroni L
    Am J Surg Pathol; 2010 Jan; 34(1):75-87. PubMed ID: 19956058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic and immunohistologic characterization of skin localization of myeloid disorders: a study of 173 cases.
    Bénet C; Gomez A; Aguilar C; Delattre C; Vergier B; Beylot-Barry M; Fraitag S; Carlotti A; Dechelotte P; Hospital V; d'Incan M; Costes V; Dereure O; Ortonne N; Bagot M; Laroche L; Blom A; Dalac S; Petrella T
    Am J Clin Pathol; 2011 Feb; 135(2):278-90. PubMed ID: 21228369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid leukemia cutis: a histologic and immunohistochemical review.
    Cibull TL; Thomas AB; O'Malley DP; Billings SD
    J Cutan Pathol; 2008 Feb; 35(2):180-5. PubMed ID: 18190442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanding the Immunophenotypic Spectrum of Neoplastic and Reactive Plasmacytoid Dendritic Cells.
    Wu SJ; Sadigh S; Lane AA; Pinkus GS
    Am J Clin Pathol; 2023 May; 159(5):455-463. PubMed ID: 36880313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow.
    Alayed K; Patel KP; Konoplev S; Singh RR; Routbort MJ; Reddy N; Pemmaraju N; Zhang L; Shaikh AA; Aladily TN; Jain N; Luthra R; Medeiros LJ; Khoury JD
    Am J Hematol; 2013 Dec; 88(12):1055-61. PubMed ID: 23940084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IRF8 may be a useful marker for blastic plasmacytoid dendritic cell neoplasm, especially with weak CD123 expression.
    Tang H; Panse G; Braddock D; Perincheri S; Xu ML; McNiff JM
    J Cutan Pathol; 2023 Jul; 50(7):595-600. PubMed ID: 37082914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blastic plasmacytoid dendritic cell neoplasm: a single-center experience.
    An HJ; Yoon DH; Kim S; Shin SJ; Huh J; Lee KH; Suh C
    Ann Hematol; 2013 Mar; 92(3):351-6. PubMed ID: 23135479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lacking CD56 expression in a relapsing cutaneous blastic plasmacytoid dendritic cell neoplasm after allogeneic bone marrow transplantation: FISH analysis revealed loss of 11q.
    Mitteldorf C; Bertsch HP; Baumgart M; Haase D; Wulf G; Schön MP; Rosenwald A; Neumann C; Kaune KM
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1225-9. PubMed ID: 21923812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+/CD56+ hematodermic neoplasm ("blastic natural killer cell lymphoma"): neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon.
    Pilichowska ME; Fleming MD; Pinkus JL; Pinkus GS
    Am J Clin Pathol; 2007 Sep; 128(3):445-53. PubMed ID: 17709319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype.
    Urosevic M; Conrad C; Kamarashev J; Asagoe K; Cozzio A; Burg G; Dummer R
    Hum Pathol; 2005 Sep; 36(9):1020-4. PubMed ID: 16153467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic study].
    Sang W; Wang CF; Cheng YF; Liu X; Li XX; Gulinar A; Li JZ; Zhang W
    Zhonghua Bing Li Xue Za Zhi; 2012 May; 41(5):326-30. PubMed ID: 22883672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.